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Abstract
Contamination of their carrion food supply with the non-steroidal anti-inflammatory drug diclofenac has caused rapid
population declines across the Indian subcontinent of three species of Gyps vultures endemic to South Asia. The
governments of India, Pakistan and Nepal took action in 2006 to prevent the veterinary use of diclofenac on domesticated
livestock, the route by which contamination occurs. We analyse data from three surveys of the prevalence and
concentration of diclofenac residues in carcasses of domesticated ungulates in India, carried out before and after the
implementation of a ban on veterinary use. There was little change in the prevalence and concentration of diclofenac
between a survey before the ban and one conducted soon after its implementation, with the percentage of carcasses
containing diclofenac in these surveys estimated at 10.8 and 10.7%, respectively. However, both the prevalence and
concentration of diclofenac had fallen markedly 7–31 months after the implementation of the ban, with the true prevalence
in this third survey estimated at 6.5%. Modelling of the impact of this reduction in diclofenac on the expected rate of decline
of the oriental white-backed vulture (Gyps bengalensis) in India indicates that the decline rate has decreased to 40% of the
rate before the ban, but is still likely to be rapid (about 18% year
21). Hence, further efforts to remove diclofenac from
vulture food are still needed if the future recovery or successful reintroduction of vultures is to be feasible.
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Introduction
Three species of vultures endemic to South Asia, oriental white-
backed vulture (Gyps bengalensis), long-billed vulture (G. indicus) and
slender-billed vulture (G. tenuirostris), are listed as being threatened
with extinction after rapid population declines in the Indian
subcontinent, which began in the 1990s [1,2,3]. The oriental
white-backed vulture population in India in 2007 was estimated at
one-thousandth of its level in the early 1990s [3]. Veterinary use of
the non-steroidal anti-inflammatory drug (NSAID) diclofenac is
the major cause of these declines [4,5,6,7]. Diclofenac has been
used to treat symptoms of disease and injury in domesticated
ungulates in many parts of the subcontinent since the 1990s [8].
The effects of diclofenac on captive oriental white-backed vulture,
African white-backed vulture (G. africanus), Cape griffon vulture (G.
coprotheres) and Eurasian griffon vulture (G. fulvus) have been studied
experimentally. In all species, death occurred within a few days
and extensive visceral gout and kidney damage were observed post
mortem [4,9,10]. Vultures that died in these experiments showed
similar pathology to that found in the majority of vulture carcasses
collected from the wild since declines began [4,5,6,9,11]. A large-
scale survey of the amount of diclofenac in liver tissue from
carcases of domesticated ungulates available to vultures as food in
India in 2004–2005 showed that the prevalence and concentration
of the drug was sufficient to cause the observed rapid population
declines [7,12]. Approximately 10% of carcasses were found to
have detectable levels of diclofenac [12].
After research had indicated the adverse effects of diclofenac on
vultures, the governments of India, Pakistan and Nepal com-
menced actions to prevent the contamination of vulture food
supplies with the drug [13]. India’s National Board for Wildlife
recommended a ban on veterinary use on 17 March 2005. In May
2006, a directive from the Drug Controller General of India was
circulated to relevant officials, requiring the withdrawal of
manufacturing licences for veterinary formulations of diclofenac.
This directive was further strengthened in 2008, when it was made
an imprisonable offence to manufacture, retail or use diclofenac
for veterinary purposes.
In this paper, we analyse data from three surveys of diclofenac
concentrations in liver samples from carcasses of domesticated
ungulates in India before and after the ban [12,14] in order to
estimate the change in the expected rate of mortality caused by
diclofenac in oriental white-backed vultures and the expected
trend in their population. Our analysis is restricted to oriental
white-backed vulture because this is the only species for which the
relationship between dose and mortality has been measured [4,9].
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19069However, we expect that our conclusions concerning this species
will also be relevant to the conservation of the two other
threatened Gyps species in South Asia.
Methods
Field sampling
Liver samples were collected from carcasses of domesticated
ungulates during three survey periods: T1 = May 2004–July
2005, T2 = April–December 2006, T3 = January 2007–
December 2008. Samples were collected from carcasses deposited
at carcass dumps managed by local government corporations, co-
operatives, private companies and individuals, and cattle welfare
charities. Sampling locations were typical of sites formerly used by
large numbers of foraging Gyps vultures. Samples were also
collected from slaughterhouses during T1 (15% of samples), but
not during subsequent surveys. Protocols for sample collection and
storage have been reported previously [12,14].
GPS co-ordinates of sample collection sites were recorded. Each
site in the T2 and T3 surveys was assigned to one of 21 site clusters
previously identified during an analysis of the T1 survey data [7].
Site-cluster assignment was based upon the site being nearer to the
geodesic centroid of a particular cluster than to that of any other
cluster. Sample sites were always within 186 km of the geodesic
centroid of their cluster. Samples were gathered opportunistically
when and where it was possible to obtain access and permission to
collect. For logistical reasons the geographical distribution of
sampling effort differed among the three surveys. Site clusters
covered in T2 and T3 were a subset of those covered during T1.
The number of samples taken in each cluster differed among
surveys.
Sample extraction and quantification of diclofenac
concentration
Weighed sub-samples of ungulate liver were homogenized in
acetonitrile. Diclofenac concentrations in the extracts were
determined by liquid chromatography-electrospray ionisation
mass spectrometry. The limit of quantification (LOQ) for this
technique, back-calculated to the concentration in wet tissue, was
0.01 ppm (0.01 mg kg
21). Detailed protocols for sample extraction
and diclofenac quantification have been reported previously
[12,14].
Statistical analysis
The objectives of our analyses were to estimate (1) changes in
the level of exposure of vultures to diclofenac over time, (2)
consequent changes in the average proportion of oriental white-
backed vultures expected to be killed by diclofenac per meal of
carrion consumed, and (3) the expected annual rate of decline of a
model population of oriental white-backed vultures that would
have been stable in the absence of diclofenac. The analysis
followed Steps 1–8 of the procedure described in a previous
analysis of the T1 survey data [7], except that Step 2 of the
procedure was omitted. This was because the previous analysis
showed that variation in the measured diclofenac concentration
among sub-samples taken from the liver of the same ungulate had
a negligible effect on the outcome of the analysis. This source of
variation could therefore be ignored. The procedure fits a
statistical model to the frequency distribution of the concentrations
of diclofenac measured in samples of liver taken from carcasses of
domesticated ungulates. It then estimates from the data for liver
the distribution of diclofenac concentrations averaged over all
edible tissues of the ungulate carcasses and, from that, the
distribution of doses of diclofenac per unit vulture body mass
ingested by vultures feeding on a mixture of tissues. The expected
average proportion of vultures killed per meal is then obtained and
this result is used in a simulation model of the vulture population
to estimate its expected rate of decline.
Step 1 of the procedure required a more elaborate treatment
than that used in the previous analysis because the present study
compares data from three surveys rather than reporting just one.
This step determines the cumulative distribution function (cdf)
V(dliver) of the concentrations dliver of diclofenac in ungulate livers.
For the purpose of the present analysis, it is necessary to
determine V(dliver) for each survey period (T1, T2 and T3), whilst
avoiding, as far as possible, the potential bias introduced by
differences among surveys in the geographical distribution of
sampling sites. In previous analysis of the T1 data [7], V(dliver)w a s
assumed to be 1 + f (U(dliver) – 1), where f is the true prevalence of
diclofenac, i.e., the proportion of livers that contained residues of
the drug, and U(dliver) is the cdf of diclofenac concentrations in
samples that contained the drug. A proportion of the livers
sampled (1 - f) have no trace of the drug. In previous analysis [7],
a third order complementary log-log distribution was used for
U(dliver) because this distribution gave a good fit to the data.
However, this distribution requires the estimation of four
parameters, in addition to f. To reduce the number of fitted
parameters required to describe the diclofenac distributions for
the three survey periods, we instead assumed that U(dliver)w a sa
Weibull distribution, which is determined by just two parameters;
a scale parameter a and a shape parameter b. Using this
formulation, U(dliver) = 1 - exp(-ad liver
b) and V(dliver)=1–f exp(-a
dliver
b). To check whether simplifying the model in this way
resulted in an appreciably poorer fit, we compared the Weibull
and third order complementary log-log distributions when fitted
to the data for samples with detectable diclofenac levels from
each of the three surveys. We fitted truncated distributions using
a maximum-likelihood method [15], left-censored at the LOQ.
We assessed the fit of each distribution using a Kolmogorov-
Smirnov one sample test [16]. As expected, because of its larger
number of fitted parameters, the third order complementary log-
log (CL-L3) distribution gave a better fit than the Weibull for all
three surveys. Kolmogorov-Smirnov’s D values for CL-L3 vs
Weibull for T1, T2 and T3 were 0.042 vs 0.049, 0.030 vs 0.035,
0.043 vs 0.048 respectively, but these differences are small and
the fit of all models was good. The significance of the
Kolmogorov-Smirnov test was P.0.40 in all cases. Hence, we
concluded that the Weibull gave an adequate fit, thus allowing a
reduction in the number of fitted parameters required and a
simplification of subsequent analysis.
If the number and thus the proportion of samples taken within
each site cluster had remained the same for all three surveys, it
would have been acceptable to estimate f, a and b separately for
each survey and then make a direct comparison of these estimates.
However, given that some of the site clusters sampled in T1 were
not sampled in T2 or T3 or both, and that different numbers of
samples were taken within clusters that were sampled in more than
one survey, we considered it necessary to model the prevalence
and concentration of diclofenac as varying with site cluster (S) and
time period (T) (see Table 1 and Figure 1 for the distribution of
samples in surveys T1 to T3). Site cluster and survey period were
treated as factors in the Weibull models. This allowed us to
simulate the prevalence and concentration of diclofenac that
would be expected if the geographical distribution of sampling had
actually been the same in all three surveys. Since models with site-
cluster effects were only used to estimate changes over time, we
reduced the number of fitted parameters required by combining
data for the seven site clusters that were only sampled in the T1
Exposure of Vultures to Diclofenac
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analyses. We used different approaches to represent site-cluster
and survey-period variation in the parameters for the prevalence
and concentration components of the model. For true prevalence
f, which is a proportion, we assumed that the odds of a sample
containing diclofenac were the product of two constants; a site-
cluster effect g and a survey-period effect h. Hence, for the ith
site cluster and the jth survey period, fij/(1 – fij), the logit
transformation of fij was assumed to be given by the product gi hj.
The scale and shape parameters a and b of the Weibull model were
assumed to be products of site-cluster (m and q) and survey-period
(n and r) effects so that aij=mi nj and bij=qi rj. The g, m and q factors
had a number of levels equal to the number of site clusters, except
that the site clusters only sampled in T1 were pooled (as explained
above). The h, n and r factors each had three levels, one for each
survey period, but the parameter values for the first period, h1, n1
and r1 were fixed at 1, so there were two parameters to be
estimated for each factor. We call these the S+T formulations of
the model for true prevalence, scale parameter and shape
parameter.
Our eventual goal was to fit a single statistical model to the data
from all three surveys with appropriate S+T formulations for the
parameters that determined prevalence and concentration.
However, we first conducted preliminary analyses separately for
(1) the prevalence and (2) the concentration components of the
model to compare the effects on model fit of the S+T formulations
of the different model parameters and other plausible model
formulations. In the analyses of prevalence, this was done by fitting
logistic regression models to the data on apparent prevalence.
Apparent prevalence was the proportion of samples with
diclofenac concentrations above the LOQ, not including the
undetected contaminated samples with levels of diclofenac below
the LOQ. A logistic regression model with the presence/absence
of detectable diclofenac as the binary dependent variable and the
additive main effects of site cluster and survey period included as
factors is equivalent to the S+T formulation of the model of true
prevalence described above. In separate analyses of diclofenac
concentrations, we fitted a truncated Weibull distribution of
concentrations, left-censored at the LOQ, using a maximum-
likelihood method [15]. This analysis only used data for samples
with detectable diclofenac. For both the logistic regression analyses
of apparent prevalence and the truncated Weibull models of
concentration, plausible alternative models of apparent prevalence
and concentration with various formulations were fitted and
compared by calculating their Akaike Information Criterion (AIC)
values.
After completing the preliminary analyses of apparent
prevalence and concentration, a combined Weibull model
including both components, with the selected S+T formulation,
was fitted to the full dataset using a maximum-likelihood method
[15]. Confidence limits for the parameters of the model were
obtained by taking 10,000 bootstrap samples of the data, with
bootstrapping being performed by site cluster. The model was
then fitted to each bootstrap sample and the central 9,500
estimates of each parameter were taken to be the 95% confidence
limits.
We estimated the impact of the observed level of diclofenac
contamination on the proportion of oriental white-backed vultures
killed by diclofenac per meal using Steps 3 – 7 of the procedure
developed previously [7]. Estimates of the parameters required for
the calculations were taken from this earlier analysis. The
procedure requires the following assumptions. (a) Vultures eat a
meals of ungulate tissue of uniform size at intervals F of either two
or three days, such that that their energetic requirements are met.
(b) The concentration of diclofenac in each meal is that found in
all edible tissues of the ungulate combined, which is proportional
to the diclofenac concentration in the animal’s liver, as determined
previously [7]. (c) The distribution of diclofenac concentrations in
meals is given by the product of the ratio of concentration in the
Table 1. Numbers of ungulate liver samples collected in each
of 21 site clusters in three survey periods: T1 = May 2004–July
2005, T2 = April–December 2006, T3 = January 2007–
December 2008.
Number of liver samples
C l u s t e r T 1T 2T 3
1 28 164 85
2 163 200 0
3 3 85 87 4
4 159 152 151
5 2 64 12 6 2
6 150 187 152
7 90 169 0
8 63 171 0
9 83 110 0
10 92 106 236
11 59 0 0
12 134 0 127
13 150 0 0
14 161 0 143
15 42 0 0
16 25 20 21
17 64 0 0
18 52 0 0
19 54 0 0
20 121 0 0
21 94 110 0











S p e c i e s T 1T 2T 3
Camel 0.1 0.0 0.2
Cattle 48.3 63.8 60.1
Water buffalo 46.6 29.7 34.9
Sheep 2.6 2.6 2.4
Goat 0.2 3.6 2.2
Horse 2.3 0.3 0.2
Unidentified 0.0 0.1 0.0
Also shown are the total numbers of samples taken, the number and
proportion of them in which diclofenac was detected, the arithmetic mean
concentration of diclofenac (ppm wet weight) in the samples in which the
compound was detected and the species composition of the ungulates from
which liver tissue was sampled.
doi:10.1371/journal.pone.0019069.t001
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concentrations fitted to the results of the survey of ungulate
carcasses described above. (d) The proportion of vultures killed by
a given dose of diclofenac is specified by a relationship fitted to
data from a dosing experiment conducted previously on captive
oriental white-backed vultures [4,9]. We used a version of this
dose-response curve that was fitted after excluding an outlier
(Vulture 11) [4,9], since inclusion of this datum leads to
unrealistically high estimates of the rate of population decline
[7]. The average proportion of vultures killed per meal, averaged
across all meals taken by the vulture population, was then obtained
from the probability density function of the dose of diclofenac per
unit vulture body weight per meal and the dose-response
relationship between diclofenac dose and the proportion of
vultures killed. Integration under the curve given by the product
of these two functions gives the average proportion of vultures
killed per meal [7].
The final step in the procedure (Step 8) [7] used the death
rate per meal, as calculated above, in a simple model of the
vulture population [5] to estimate the population’s expected
rate of decline. The model assumes that the population
would have demographic rates such that it is stable in the
absence of diclofenac, and that the annual adult survival
rate S0 is either 0.90 or 0.97. These survival values were
considered to span the plausible range in a previous modelling
study [5]. The interval between meals F is assumed to be either
2 or 3 days. Other details of the model have been described
previously [5]. Confidence limits for death rate per meal and
population decline rate were obtained using sets of 10,000
bootstrap and Monte Carlo parameter estimates as described
previously [7].
Results
Differences among surveys in diclofenac prevalence and
concentration
Liver samples were taken from a large number of sites
distributed across the northern half of India (Table 1, Figure 1),
and came predominantly from carcasses of cattle (Bos indicus, B.
taurus and hybrids) and water buffalo (Bubalus bubalis). The
proportion of samples with detectable diclofenac (apparent
prevalence), the cumulative distribution of diclofenac concen-
trations and the arithmetic mean concentration in those
samples with detectable levels were broadly similar between
the two surveys conducted before and just after the implemen-
tation of the ban on diclofenac use for veterinary purposes (T2
cf. T1, Table 1). However, apparent prevalence and mean
concentration were both substantially lower in the third
survey than in the previous two (T3 cf. T2 and T1, Table 1,
Figure 2).
The geographical distribution of samples differed among the
three surveys (Table 1, Figure 1). Only seven of the 21 site clusters
were sampled in all three surveys. Five site clusters were sampled
in T1 and T2, but not in T3, two site clusters were sampled in T1
and T3, but not in T2, and seven site clusters were only sampled in
T1 (Table 1). A higher proportion of the site clusters located in
western India were sampled in more than one survey than was the
case for clusters in the east (Figure 1).
Differences in the distribution of sampling sites among surveys
might lead to spurious differences in prevalence or the
distribution of concentrations of diclofenac if (a) these varied
consistently with location, and (b) site clusters covered in surveys
T2 and T3 differed in prevalence or concentration distribution
Figure 1. Locations of sampling site clusters in India. The map shows centroids of 21 site clusters at which liver samples were obtained from
carcasses of domesticated ungulates. Numbers next to the symbols identify site clusters listed in Table 1. Triangles show clusters sampled in all three
surveys (T1, T2, T3), squares show clusters sampled in T1 and T2, diamonds, T1 and T3, and circles T1 only.
doi:10.1371/journal.pone.0019069.g001
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to a lesser extent. A previous analysis of data from T1 has already
revealed significant geographical variation in apparent prevalence
[12]. Comparison of apparent prevalence between pairs of survey
periods indicated that significant positive correlations also existed
across site clusters. Clusters with higher than average apparent
prevalence in one survey also tended to have high prevalence in
other surveys (Spearman correlation coefficients [16]: T1 vs T2,
rS=0.504, one-tailed P=0.05; T1 vs T3, rS=0.483, one-tailed
P=0.10; T2 vs T3, rS=0.714, one-tailed P=0.05). Hence,
apparent prevalence not only varied geographically, but the
pattern of variation among site clusters tended to be consistent
through time. However, the equivalent correlation analyses for
mean diclofenac concentration in those samples with detectable
levels gave no indication that mean concentrations varied
consistently among site clusters in different time periods
(Spearman correlation coefficients: T1 vs T2, rS=20.067; T1
vs T3, rS=0.321, one-tailed P=0.25; T2 vs T3, rS=0.143, one-
tailed P.0.25).
Although differences among surveys in the geographical
distribution of sampling sites were present and might cause
spurious differences in estimates of diclofenac prevalence and
concentration distribution, simple non-parametric analyses indi-
cated that differences between surveys remained even after site-
cluster differences had been allowed for. A Wilcoxon signed ranks
test [16] on differences between pairs of apparent prevalence
values for the same cluster during different time periods indicated
that apparent prevalence was significantly lower in T3 than in T1
(T
+=39, N=9, one-tailed P=0.021). However, there was no
significant difference for comparisons among the other survey
pairs (T2 vs T1, T
+=43, N=12, one-tailed P=0.396; T3 vs T2,
T
+=19, N=7, one-tailed P=0.234). The equivalent analyses for
mean diclofenac concentrations in those samples with detectable
levels indicated that concentrations were also lower in T3 than in
T1 (T
+=27, N=7, one-tailed P=0.016), and had a marginally
significant tendency to be lower in T3 than T2 (T
+=18, N=6,
one-tailed P=0.078). There was no significant difference between
mean concentrations in T2 and T1 (T
+=35, N=10, one-tailed
P=0.246).
These analyses suggest that both the apparent prevalence of
diclofenac and its concentration were lower in T3 than in the
previous two surveys. However, they also indicate that there was a
consistent geographical variation in prevalence, so quantification
of the changes requires more elaborate modelling to adjust for
differences among surveys in the geographical distribution of
sampling.
Site-cluster and time-period effects on apparent
prevalence and diclofenac concentration
Adjustments for possible biases caused by differences among
surveys in the geographical distribution of sampling required
models of the prevalence and concentration of diclofenac that had
independent main effects of site cluster (S) and time period (T). We
call these S+T models and described the way we used them in the
Methods section. We performed two preliminary analyses,
separately for data for apparent prevalence and concentration,
to see how the fit of the S+T models compared with that of other
plausible model formulations.
Comparisons of AIC values among logistic regression models
of apparent prevalence in relation to site cluster and time period
indicated that those models with the effects of S and T included
on their own fitted the data substantially better than did the null
m o d e l( T a b l e2 ;M o d e l sBa n dCc f .M o d e lA ) .T h ee f f e c tu p o n
AIC of site cluster was considerably larger than that of time
period. However, a model in which the odds of a sample having
detectable diclofenac were given by the product of a site-cluster
effect and a survey-period effect (S+T) had a considerably
lower AIC than either of the single factor models (Table 2;
Model D cf. Models B and C). A full model, with proportions
specific to each site-time combination (S.T), gave an even lower
AIC value, but the AIC difference between this and the S+T
model was modest, indicating that the S+T model (Model D)
provides an adequate description of the data on apparent
prevalence.
Comparisons of AIC values were made among truncated
Weibull distribution models of the distributions of diclofenac
concentrations in those samples with detectable levels (Table 3).
In this case, it was possible to formulate the model so that the
scale parameter a and the shape parameter b were separately or
both affected by S and T. A model in which the scale parameter
varied with time period but not site cluster, and in which the
shape parameter did not vary with S or T, gave the lowest AIC
value of all models considered (Table 3; Model 2). However,
there was only a small difference in AIC between this model and
one with an S+T formulation of the scale parameter and a
constant shape parameter (Table 3; Model 10). Other models
which had the shape parameter as well as the scale parameter
dependent on S and/or T did not give a substantial reduction in
AIC compared with Model 10. Given that an S+T formulation is
necessary to allow adjustment for possible bias caused by
differences among surveys in the geographical distribution of
sampling, we concluded that the S+T model (Model 10) of
concentration fits sufficiently well to be used for this purpose.
Hence, we decided that the combined model of prevalence and
concentration should have the same formulation as that in Model
D of apparent prevalence and that in Model 10 of diclofenac
concentration.
Figure 2. Comparison of the distributions of diclofenac
concentrations before and after the ban on the veterinary
use of diclofenac. Cumulative distributions of diclofenac concentra-
tion (ppm wet weight) in ungulate liver samples from three surveys:
red=T1, pre-ban, green=T2, soon after the ban, blue=T3, 7–31
months after the ban are shown by the stepped lines. The curves show
cumulative Weibull distributions fitted separately to the data for each
survey. Fitted values of prevalence f, the scale a and shape b parameters
respectively were T1, 0.110, 1.336 and 0.592; T2, 0.122, 1.458 and 0.597;
T3, 0.061, 1.844 and 0.673.
doi:10.1371/journal.pone.0019069.g002
Exposure of Vultures to Diclofenac
PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e19069Combined Weibull model of diclofenac prevalence and
concentration
We fitted a combined model in which both the true prevalence
of diclofenac f and the scale parameter a of the Weibull
distribution of diclofenac concentrations had an S+T formulation,
whilst the shape parameter b of the Weibull distribution was
assumed not to vary with S or T. We then used a maximum-
likelihood method [15] to estimate the values of the true
prevalence f1 and the scale parameter a1 across all clusters using
the data for the first survey period (T1) alone. This was done by
estimating the values of f1 and a1 whilst ignoring the effects of site
cluster, and with the shape parameter b fixed at the value obtained
from the combined model of the data from all three surveys with
an S+T formulation for both prevalence and the scale parameter.
The values of the time-period effects on prevalence and on the
scale parameter were then taken from the combined analysis (the h
and n effects: see Methods) and used to calculate f2 and f3 and a2
and a3 values for surveys T2 and T3 respectively. The time-period
effects h on the prevalence parameter were multiplied by f1/(1 - f1)
and then back-transformed to give f2 and f3. The time-period
effects n on the scale parameter were multiplied by a1 to give a2
and a3. This procedure simulated the results expected if the
geographical distribution of samples in T2 and T3 had been the
same as that in T1. These time-period specific estimates of f and a,
together with the estimate of the shape parameter b (assumed to be
common to all three time periods) are shown in Table 4. The
arithmetic mean diclofenac concentration, calculated across all
samples that contained residues of the drug, including those with
Table 2. Comparisons between the residual deviance and Akaike Information Criterion (AIC) of various logistic regression models
of the variation among site clusters (S) and survey time periods (T) in the apparent prevalence of diclofenac (the proportion of liver
samples with detectable levels of the drug).
Model Model specification Residual deviance Number of parameters AIC DAIC
A C 184.39 1 186.39 114.39
B T 154.45 3 160.45 88.45
C S 53.84 15 83.84 11.84
DS +T 40.81 17 74.81 2.81
E S.T 0.00 36 72.00 0.00
A null model in which the proportion was assumed to be constant (C) across site clusters and time periods was compared with models in which the odds of a sample
having detectable diclofenac varied either among site clusters or time periods or was given by the product of a site-cluster effect and a time-period effect (denoted
S+T). A full model with proportions specific to each site-time combination is denoted S.T.
doi:10.1371/journal.pone.0019069.t002
Table 3. Comparisons between the residual deviance and Akaike Information Criterion (AIC) of various Weibull models of the











1 C C 6391.58 2 6395.58 1.42
2 T C 6386.16 4 6394.16 0.00
3 C T 6390.24 4 6398.24 4.08
4 T T 6385.46 6 6397.46 3.30
5 S C 6366.60 16 6398.60 4.44
6 C S 6375.62 16 6407.62 13.45
7 S S 6336.39 30 6396.39 2.23
8 S T 6365.56 18 6401.56 7.40
9 T S 6370.11 18 6406.11 11.95
10 S+T C 6359.26 18 6395.26 1.10
11 C S+T 6375.01 18 6411.01 16.84
12 S+T T 6358.27 20 6398.27 4.10
13 T S+T 6369.89 20 6409.89 15.73
14 S+TS +T 6331.04 34 6399.04 4.88
15 S.T T 6347.35 36 6419.35 25.18
16 S.T S.T 6283.50 66 6415.50 21.34
A null model in which the scale and shape parameters a and b of the Weibull distribution of concentrations of diclofenac were assumed to be constant (C) across sites
and time periods is compared with models in which the scale parameter a and/or the shape parameter b varied with site cluster or time period or were given by the
product of S and T effects (denoted by S+T). The full model with parameters specific to each site cluster and time combination is denoted by S.T.
doi:10.1371/journal.pone.0019069.t003
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values for each survey period. The adjusted estimates from the
combined model showed that the true prevalence of diclofenac
was similar in T1 and T2, but that true prevalence in T3 was
lower than in T1 and in T2 (Table 4). The ratio of values in T3 to
those from the earlier surveys indicated a reduction in the true
prevalence of diclofenac in T3 to about 60% of its value in T1 and
T2 (Table 5).
A similar pattern was seen for the mean concentration of
diclofenac in those samples in which the drug was estimated to be
present, which was also lower in T3 than in T1 or T2 (Table 4).
Calculation of the ratio of values in T3 to those from the earlier
surveys indicated a reduction in mean concentration in T3 to 48%
and 57% of the values in T1 and T2 respectively (Table 5).
Probability density functions (pdfs) calculated from the combined
model illustrate this pattern, with the density being lower across all
diclofenac concentrations for T3 than for T1 and T2, showing
lower prevalence in T3, and the peak of the probability density
function occurred at a lower concentration in T3 than in T1 and
T2 (Figure 3).
Proportion of vultures expected to be killed per meal
We estimated the impact of the observed levels of diclofenac
contamination on the proportion of oriental white-backed vultures
that would be killed per meal using Steps 3 – 7 of the procedure
developed earlier for the analysis of the T1 data [7]. The
calculation is illustrated in Figure 4, which shows the curve that is
obtained by multiplying together the probability density function
of the dose of diclofenac per unit vulture body weight per meal and
the dose-response relationship between the proportion of vultures
killed and the dose of diclofenac ingested. The example shown is
for the interval between meals F=3. The integral under this curve
gives the proportion of birds killed per meal. For both of the
feeding intervals, F=2 and F=3, the death rate per meal was
slightly lower in T2 than in T1, but, markedly lower in T3 than in
both T2 and T1 (Table 6). The death rate per meal in T3 was 21 –
24% of that in T1 and 26 – 30% of that in T2 (Table 5).
Expected rate of decline of the oriental white-backed
vulture population in India
The decline rate of the Indian oriental white-backed vulture
population, expected from the exposure to diclofenac indicated by
survey T1, was 78 – 79% per year with F=2, and 80 – 81% per
year with F=3. For both feeding intervals the rate of expected
population decline was slightly lower in T2 than in T1, but
markedly lower in T3 than in T2 and T1 (Table 6). The decline
rate in T3 was 35–41% of that in T1 and 39 - 45% of that in T2
(Table 5). Hence, there was little change in the expected rate of
population decline in period T2, immediately after the implemen-
tation of the ban on veterinary manufacture of diclofenac in 2006,
Table 4. Estimates of the parameters of a model which describes the true prevalence f of diclofenac in liver samples taken during
three surveys of ungulate carcasses (T1, T2, T3) and the scale a and shape b parameters of the Weibull distribution of diclofenac
concentrations (ppm wet weight).
T1 T2 T3
Parameter Estimate 95% C.L. Estimate 95% C.L. Estimate 95% C.L.
f 0.108 0.086 - 0.130 0.107 0.085 - 0.129 0.065 0.021 - 0.101
a 1.305 0.700 - 1.951 1.444 0.763 - 2.115 2.071 1.020 - 3.150
b 0.630 0.578 - 0.697 0.630 0.578 - 0.697 0.630 0.578 - 0.697
Mean concentration 0.927 0.229 - 1.565 0.789 0.214 - 1.363 0.446 0.082 - 0.800
The value b is assumed to be common to all three surveys. Also shown is the arithmetic mean concentration of diclofenac (ppm wet weight) for those samples which
contained the compound, calculated from a and b. Parameter estimates and their bootstrap 95% confidence limits are shown for each of three surveys.
doi:10.1371/journal.pone.0019069.t004
Table 5. Estimates of changes between three surveys of ungulate carcasses (T1, T2, T3) in the true prevalence f of diclofenac, the
arithmetic mean concentration of diclofenac in livers of animals in which it was present (ppm wet weight), the estimated mean
percentage of vultures killed by a meal of mixed tissues, and the annual percentage rate of decline of the vulture population.
T2:T1 T3:T1 T3:T2
Parameter FS 0 Ratio 95% C.L. Ratio 95% C.L. Ratio 95% C.L.
f - - 0.987 0.971 - 1.007 0.598 0.253 - 0.859 0.605 0.252 - 0.874
Mean conc. - - 0.851 0.699 - 1.003 0.480 0.360 - 0.601 0.565 0.430 - 0.699
Death rate 2 - 0.803 0.608 - 1.054 0.211 0.050 - 0.407 0.262 0.065 - 0.483
Death rate 3 - 0.828 0.655 - 1.044 0.244 0.073 - 0.443 0.295 0.094 - 0.513
Decline rate 2 0.90 0.906 0.655 - 1.019 0.357 0.057 - 0.884 0.394 0.074 - 0.886
Decline rate 2 0.97 0.903 0.654 - 1.020 0.351 0.057 - 0.879 0.388 0.073 - 0.881
Decline rate 3 0.90 0.924 0.721 - 1.017 0.413 0.089 - 0.869 0.447 0.114 - 0.872
Decline rate 3 0.97 0.921 0.719 - 1.017 0.406 0.087 - 0.863 0.440 0.113 - 0.866
The interval between meals F was assumed to be two or three days and annual adult survival in the absence of diclofenac S0 was assumed to be either 0.90 or 0.97.
Ratios of parameter estimates and their bootstrap 95% confidence limits are shown for each pairwise comparison of surveys.
doi:10.1371/journal.pone.0019069.t005
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appreciably (Figure 5).
Discussion
Our study shows that both the prevalence and concentration of
diclofenac in carcasses of domesticated ungulates available as food
for vultures in India has fallen markedly since a ban on the
veterinary use of diclofenac was implemented. Between the period
prior to the ban and the period 7–31 months after the first
implementation by the Government of India of measures to
prevent the use of diclofenac for veterinary purposes (period T3)
decreased by about about half. The estimates of true prevalence,
adjusted for samples with low-level contamination below the limit
of quantification and for site-cluster effects, were 6.5% in T3,
compared with 10.8% and 10.7% in surveys T1 and T2
respectively. Hence, our conclusion about the change in
prevalence between surveys holds with or without the statistical
adjustments. Similarly, the unadjusted estimates of mean concen-
tration in Table 1 and the adjusted values for mean concentration
in Table 4 both show the same pattern of little difference between
T1 and T2 but a substantial decline by period T3. We consider
that these declines in prevalence and concentration are likely to be
representative of the situation in north-western India because of
the wide distribution of sampling sites and scale of sampling
undertaken (.4,500 carcass samples analysed in T1 – T3). The
magnitude of the decline in diclofenac prevalence was probably
slightly underestimated because some T1 samples, but no T2 or
T3 samples, were taken from slaughterhouses, where diclofenac
prevalence was lower than at carcass dumps [12]. However,
because only seven of the samples taken at slaughterhouses in the
T1 survey were from a site cluster which was sampled in later
surveys, this effect is extremely small.
Figure 3. Comparison of probability density functions of
diclofenac concentrations in ungulate liver before and after
the ban on the veterinary use of diclofenac. Fitted probability
density functions are shown of diclofenac concentration (ppm wet
weight) in ungulate liver samples from three surveys: red=T1, pre-ban,
dark green=T2, soon after the ban, dark blue=T3, 7–31 months after
the ban. The curves are derived from a Weibull model in which both the
true prevalence of diclofenac f (including those with concentrations ,
LOQ) and the scale parameter a of the Weibull distribution of
concentrations of diclofenac in those samples are determined by a
site-cluster effect and a survey period effect. The shape parameter b of
the Weibull distribution is assumed not to vary with site-cluster or
survey period. Values of f and a in all three surveys were adjusted so
that the results simulate those expected if the 21 site-clusters covered
by the T1 (pre-ban) survey had been covered at the same sampling
intensity in the second T2 and third T3 surveys.
doi:10.1371/journal.pone.0019069.g003
Figure 4. Comparison of probability density functions of diclofenac dose per unit vulture body weight from ungulate tissue before
and after the ban on the veterinary use of diclofenac. Probability density functions are shown of estimated diclofenac dose (mg kg
21 wet
weight) per meal for birds eating a mixture of all edible ungulate tissues and feeding at intervals of three days. Results are shown for three surveys:
red=T1, pre-ban, dark green=T2, soon after the ban, dark blue=T3, 7–31 months after the ban. The proportion of vultures expected to be killed by a
given dose of diclofenac is shown by the dose-response curve (black, with right-hand y axis). The products of the dose probability density functions
and the dose-response curve are shown by the orange, light green and light blue curves for surveys T1, T2 and T3 respectively. The areas under these
curves give the estimated proportion of vultures killed per meal.
doi:10.1371/journal.pone.0019069.g004
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the expected decline rate of the oriental white-backed vulture
population based upon the T1 carcass survey carried out before
the ban on diclofenac use was introduced were very similar to
those made previously using the same data but with a different
method for modelling the distribution of concentrations [7]. This
indicates that the changes made in the present analysis to the
methods, principally the replacement of the complementary log-
log distribution by the Weibull distribution, had a negligible effect
on the results.
Based on the data on prevalence and concentration of
diclofenac residues presented here and the results of modelling
the impact of these residues on the vulture population, the
expected rate of decline of the Indian oriental white-backed
vulture population has been cut by more than half compared with
what it was before the ban. We showed previously that the
expected rate of vulture population decline estimated by our
method from surveys of diclofenac in ungulate carcasses was
higher, though not significantly so, than that observed using
repeated counts of vultures during the same period [7]. There are
Table 6. Estimates of the mean percentage of vultures killed by a meal of mixed tissues assuming that the interval between meals
F was two or three days, and the annual percentage rate of decline of the vulture population, assuming the two values of F and
annual adult survival in the absence of diclofenac S0 of either 0.90 or 0.97.
T1 T2 T3
Parameter FS 0 Estimate 95% C.L. Estimate 95% C.L. Estimate 95% C.L.
Death rate 2 - 0.821 0.076 - 3.451 0.660 0.049 - 3.072 0.173 0.004 - 1.231
Death rate 3 - 1.303 0.202 - 4.367 1.080 0.146 - 3.946 0.318 0.016 - 1.649
Decline rate 2 0.90 79.2 14.5 - 99.9 71.8 9.8 - 99.7 28.3 0.9 - 88.4
Decline rate 2 0.97 78.3 14.0 - 99.9 70.7 9.5 - 99.7 27.5 0.9 - 87.9
Decline rate 3 0.90 81.1 23.3 - 99.7 74.9 17.9 - 99.4 33.5 2.1 - 86.2
Decline rate 3 0.97 80.2 22.5 - 99.6 73.8 17.3 - 99.4 32.5 2.0 - 85.7
Parameter estimates and their bootstrap 95% confidence limits are shown for each of three surveys of ungulate carcasses (T1, T2, T3).
doi:10.1371/journal.pone.0019069.t006
Figure 5. Changes in the expected rate of decline of the oriental white-backed vulture population in India. Circles show the estimated
rate of population decline, as a ratio relative to that determined from the T1 survey results in 2004 – 2005. Values are plotted at the mean sampling
time for each of the surveys. Horizontal rectangles show the duration of the period covered by the sample collection for each survey. Vertical lines
show 95% confidence limits for the ratios. Each of the four adjacent points in a set represents the result for a combination of assumptions (from left
to right: F=2,S0=0.90; F=2,S0=0.97; F=3,S0=0.90; F=3,S0=0.97). Arrows show the timing of the recommendation by the National Board for
Wildlife for a ban on the veterinary use of diclofenac and the withdrawal by the Drug Controller General of manufacturing licences for veterinary
formulations of the drug.
doi:10.1371/journal.pone.0019069.g005
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the restriction of the remaining vultures to areas with lower than
average diclofenac prevalence and potential selection for vultures
with a higher resistance to the toxic effects of diclofenac [7].
However, despite the possibility of a discrepancy in its absolute
level, it seems probable that our conclusion about the decrease in
the expected rate of population decline is reliable, because the
same assumptions and modelling procedure were used for all three
survey periods.
Although the observed reduction in the level of diclofenac
contamination of the vulture food supply in India is an
encouraging sign of a potential future solution to this urgent
conservation problem, it is clear from the continued presence of
diclofenac in many carcasses that the problem has not yet been
overcome. The most recent estimate of the rate of decline in the
oriental white-backed vulture population in India from repeated
road transect counts is an annual decline of 44% year
21 between
2000 and 2007 [3]. Our ungulate carcase survey results from
survey period T3 suggest a recent reduction of the expected rate of
decline to less than half of the rate before the ban on diclofenac
use. Hence, by scaling down the rate of decline from road transect
surveys in 2000–2007 by the ratio of expected decline rates before
and after the ban reported in this paper, we estimate an annual
decline rate in 2007–2008 at 18% year
21. This remains a rapid
rate of population decline compared with rates for most other
threatened bird populations [17] and one that is unlikely to be fully
counteracted by compensatory in situ conservation measures such
as nest protection and supplementary feeding. Only a very low
proportion (, 1%) of ungulate carcasses is required to contain a
lethal levels of diclofenac in order to account for the rapid pre-ban
population declines of Gyps vultures [5], so it may be necessary to
remove nearly all diclofenac from the vulture food supply if
populations are to recover or be re-introduced successfully from
captive-bred stock. There is also a possibility that an Allee effect
may occur, caused by reduced social facilitation of foraging at low
vulture population densities [18]. This also suggests that almost
complete elimination of diclofenac from vulture food may be
needed.
Our results indicate that a substantial decrease has occurred in
the level of diclofenac contamination in India, but the continued
presence of levels of diclofenac lethal to vultures in ungulate
carcasses remains a source of major concern. It is now illegal to
import, manufacture, retail or use diclofenac for veterinary
purposes in India and the continued presence of residues of the
drug in ungulate carcasses in 2007–2008 must therefore be caused
by illegal veterinary use. Surveys of pharmacy shops in India
confirm that, while diclofenac packaged and labelled for veterinary
use was rarely offered for sale for use on livestock after the 2006
ban, human formulations of drug were being sold widely for
veterinary use in place of veterinary formulations. A similar
situation probably exists in Nepal and Pakistan. Pharmacies in
India often dispense both human and veterinary medicines, in
which case their holding stocks of human diclofenac is not an
offence. Dispensing human formulations of diclofenac for use on
livestock, together with informal and illegal dispensing of human
diclofenac for veterinary purposes by unregistered people,
probably accounts for the continued contamination of ungulate
carcasses we have observed. Restrictions on the size of vials of
injectable human diclofenac to make it less easy to use human
formulations on livestock may help to eliminate these illegal
practices. A similar situation may also exist in the Punjab province
of Pakistan, where diclofenac-caused mortality of oriental white-
backed vultures continued after government action to prevent its
veterinary use [19]. If the recovery of wild vulture populations is to
be achieved, additional efforts are needed to complete the removal
of diclofenac from their food supply and to prevent its replacement
by other lethal NSAIDs such as ketoprofen [14,20]. Further effort
is also needed to promote the use of the alternative veterinary
NSAIDs known not to pose a risk to vultures. At present, the only
veterinary NSAID used in India that is known to have low toxicity
to vultures is meloxicam [21,22].
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